Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Tampa, Florida
- Most recent report
- 8-K, filed Sep 4, 2026
- Incorporated
- Nevada
- Filings on record
- 923 filings
- On EDGAR
- CIK 1498382
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 67
News 8 of 224
- 8-K Current report on a material event Sep 4, 2026
- 8-K Current report on a material event Aug 21, 2026
- 8-K Shareholder vote results Aug 19, 2026
- 8-K Quarterly results Aug 14, 2026
- 8-K Current report on a material event Aug 13, 2026
- 8-K Current report on a material event Jul 29, 2026
- 8-K Current report on a material event Jul 7, 2026
- 8-K Current report on a material event Jun 17, 2026
Prospectuses and Registrations 8 of 99
- 424B5 Prospectus supplement for an offering Apr 8, 2026
- 424B5 Prospectus supplement for an offering Dec 10, 2025
- 424B3 Prospectus supplement for an offering Nov 25, 2025
- S-3 Shelf registration statement Nov 3, 2025
- 424B3 Prospectus supplement for an offering Oct 31, 2025
- 424B3 Prospectus supplement for an offering Sep 26, 2025
- S-1/A Registration statement for an offering, amended Sep 18, 2025
- S-1 Registration statement for an offering Aug 12, 2025
Proxies 8 of 21
- DEFA14A Extra proxy material Jul 9, 2026
- DEF 14A Proxy statement for a shareholder vote Jul 9, 2026
- PRE 14A Preliminary proxy statement Jun 26, 2026
- DEF 14A Proxy statement for a shareholder vote May 17, 2024
- DEF 14A Proxy statement for a shareholder vote Sep 11, 2023
- PRE 14A Preliminary proxy statement Sep 1, 2023
- DEFA14A Extra proxy material Mar 31, 2023
- DEF 14A Proxy statement for a shareholder vote Mar 31, 2023
Ownership 8 of 360
- SCHEDULE 13D/A Large holder reported an active stake, amended Aug 28, 2026
- 4 Insider reported a trade May 29, 2026
- 4 Insider reported a trade Feb 17, 2026
- 4 Insider reported a trade Feb 17, 2026
- SCHEDULE 13G Large holder reported a passive stake Feb 17, 2026
- 4 Insider reported a trade Feb 17, 2026
- 4 Insider reported a trade Feb 17, 2026
- 4 Insider reported a trade Feb 17, 2026
Other 8 of 152
- ARS Annual report sent to shareholders Jul 9, 2026
- D Nov 10, 2025
- EFFECT Notice that a registration became effective Sep 26, 2025
- UPLOAD Comment letter from SEC staff Sep 25, 2025
- CORRESP Reply to SEC staff Sep 24, 2025
- CORRESP Reply to SEC staff Sep 18, 2025
- UPLOAD Comment letter from SEC staff Aug 28, 2025
- CORRESP Reply to SEC staff Aug 25, 2025
Everything here comes from TuHURA Biosciences, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.